Literature DB >> 23348971

Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden.

Bengt Zöller1, Henrik Ohlsson, Jan Sundquist, Kristina Sundquist.   

Abstract

Venous thromboembolism (VTE) clusters in families, but the familial risk of VTE has only been determined in first-degree relatives. This nationwide study aimed to determine the familial risk of VTE in first-, second- and third-degree relatives of affected individuals. The Swedish Multi-Generation Register was linked to Hospital Discharge Register data for the period 1987-2009. This was a case-cohort study. Odds ratios (ORs) for VTE were calculated for individuals whose relatives were hospitalised for VTE, as determined by the International Classification of Diseases (ICD), and those whose relatives were unaffected by VTE. The familial OR for VTE was 2.49 in siblings (95% confidence interval [CI] 2.40-2.58), 2.65 in children (2.50-2.80), 2.09 in parents (2.03-2.15), 1.52 in maternal half-siblings (1.26-1.85), 2.34 in paternal half-siblings (2.00-2.73), 1.69 in nieces/nephews (1.57-1.82), 1.47 in cousins (1.33-1.64), and 1.14 in spouses of individuals diagnosed with VTE (1.09-1.18). Familial clustering was stronger at young ages. The familial transmission was slightly stronger for males compared with females but was only significant for siblings 1.13 (1.05-1.22) and parents 1.11 (1.05-1.78) of probands. The present data showing an increased VTE risk among not only first-degree relatives but also second- and third-degree relatives indicate that the genetic component of the familial clustering of VTE is strong. Family history is a potentially useful genetic surrogate marker for clinical VTE risk assessment, even in second- and third degree-relatives.

Entities:  

Mesh:

Year:  2013        PMID: 23348971     DOI: 10.1160/TH12-10-0743

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  19 in total

Review 1.  Role of thrombophilia testing: con.

Authors:  Scott M Stevens
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

Review 2.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

3.  Differential expression of 5-HT-related genes in symptomatic pulmonary embolism patients.

Authors:  Yun Jin; Lemin Wang; Qianglin Duan; Zhu Gong; Fan Yang; Yanli Song
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 4.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

5.  Identification of unique venous thromboembolism-susceptibility variants in African-Americans.

Authors:  John A Heit; Sebastian M Armasu; Bryan M McCauley; Iftikhar J Kullo; Hugues Sicotte; Jyotishman Pathak; Christopher G Chute; Omri Gottesman; Erwin P Bottinger; Joshua C Denny; Dan M Roden; Rongling Li; Marylyn D Ritchie; Mariza de Andrade
Journal:  Thromb Haemost       Date:  2017-02-16       Impact factor: 5.249

Review 6.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

7.  Characterization of immune cells and perforin mutations in familiar venous thromboembolism.

Authors:  Qianglin Duan; Wei Lv; Minjun Yang; Fan Yang; Yongqiang Zhu; Hui Kang; Haoming Song; Shengyue Wang; Hui Dong; Lemin Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

8.  Venous thromboembolism and varicose veins share familial susceptibility: a nationwide family study in Sweden.

Authors:  Bengt Zöller; Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  J Am Heart Assoc       Date:  2014-08-26       Impact factor: 5.501

Review 9.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.

Authors:  Shannon M Bates; Saskia Middeldorp; Marc Rodger; Andra H James; Ian Greer
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.